Search
Selected: All

Type III secretion pathway in aeromonas salmonicida , and...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Urease-based vaccine and treatment for helicobacter infection

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of Galectin-3 to promote the re-epithelialization of wounds

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of HIV-1 gp120 and gp160 proteins modified in the v3...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of HMGB1 for protection against ischemia reperfusion injury

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of integrin antagonists to inhibit angiogenesis

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of intercellular adhesion molecules, and their binding ligan

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of OX-2 to inhibit fetal loss

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of passive myostatin immunization in egg laying vertebrates

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of poxviruses as enhancer of specific immunity

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of proteins as anti-diabetes agents

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of soluble CD14 for treatment of type 2 diabetes mellitus

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of the M3 protein of MHV68 to block binding of a...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Vaccination against diseases resulting from pathogenic responses

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Vaccination and methods against diseases resulting from pathogen

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Vaccination and methods against diseases resulting from pathogen

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Vaccination with peptide of MHC class II molecules for treatment

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Vaccine adjuvant

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Vaccine against cancer diseases that are associated with the...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Vaccine against helminth infection comprising Sm-14 fatty acid b

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.